Diabetes UK Basic Science Award
15:00 - 15:05
Dysregulated Hippo signalling drives beta cell vulnerability and reveals a novel therapeutic target in type 1 diabetes
Sophia Bigot, PDRA in Pancreatic Islet Biology in Diabetes, Biomedical Institute for Multimorbidity (BIM), Centre for Biomedicine, Hull York Medical School (HYMS), University of Hull
15:06 - 15:11
Mesenchymal stromal cell-derived extracellular vesicles deliver microRNAs to improve islet function
Wen Hong Tzu, Post Doctoral Research Fellow, King's College London
15:12 - 15:17
Do the small things matter? The relationship between pancreas development post-birth and Type 1 Diabetes disease heterogeneity
Teifion Luckett, Postdoctoral Research Associate, University of Exeter
15:18 - 15:23
M6PR controls insulin secretion and incretin responses by protecting β-cell lysosomal function
Rosa Alen, Research Associate, Section of Cell Biology and Functional Genomics, Department of Metabolism, Digestion and Reproduction, Imperial College London
15:24 - 15:29
Proinflammatory cytokine stress leads to PC1/3-driven GLP-1 production from alpha-cells and delta-cell GLP-1R upregulation in rodent islets.
Hannah Abdu, Student, University of Oxford
Diabetes UK Clinical Science Award
15:30 - 15:35
Isle of wight diabetes project; structured tabletop review and treatment optimisation improves glycemic category in early onset type 2 diabetes
George Gavoyannis, FY1 Doctor, Isle of Wight NHS Trust
15:36 - 15:41
Precision medicine in type 2 diabetes: Expansion of a 5-drug class treatment selection model to include Semaglutide
Pedro Cardoso, Research Associate, University of Exeter
15:42 - 15:47
Progression to type 2 diabetes postpartum and 15-year vascular outcomes
Sahana Mahesh, Foundation Doctor, University Hospitals Liverpool Group
15:48 - 15:53
Novel blood protein biomarkers robustly discriminate Type 1 Diabetes from Type 2 Diabetes
Kashyap Patel, Associate Professor, University of Exeter
15:54 - 15:59
Deploying genetic risk scores for type 1 and type 2 diabetes to aid classification of diabetes in early-onset lean diabetes
Raymond Win, Doctoral Fellow, Imperial College London